Nmda Receptor Antagonists Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Nmda Receptor Antagonists stocks.

Nmda Receptor Antagonists Stocks Recent News

Nmda Receptor Antagonists

NMDAR (N-methyl-D-aspartate receptor) antagonists are a class of drugs that block the activity of the NMDAR, a type of glutamate receptor found in the brain. These drugs are used to treat a variety of neurological and psychiatric disorders, including schizophrenia, bipolar disorder, and Alzheimer's disease. They are also being studied for their potential to treat other conditions, such as chronic pain and addiction.

Browse All Tags